Literature DB >> 1302564

A case-control study of the etiology of Ewing's sarcoma.

D M Winn1, F P Li, L L Robison, J J Mulvihill, A E Daigle, J F Fraumeni.   

Abstract

An interview case-control study was undertaken to search for risk factors for Ewing's sarcoma. The 208 cases, aged 5 months to 22 years at diagnosis and all white but one, were identified from hospitals participating in the Intergroup Ewing's Sarcoma Study therapeutic trials. Two controls were sought for each case: a sibling control and an age-matched regional population control identified through random-digit dialing telephone procedures. A questionnaire was administered to the parents of cases and controls. Parents were more likely to have smoked during the pregnancy with the case than during the pregnancy with the unaffected sibling. Risks rose with the number of cigarettes the mother smoked per day during the pregnancy. Concepti exposed to less than 1 pack/day were at 3.2 times the risk, and those exposed to 1 pack or more were at 6.7 times the risk of the nonexposed. However, risks associated with smoking were lower and not statistically significant in analyses using the region-matched controls. Hernias, mostly umbilical and inguinal, were diagnosed six times more frequently among the cases compared to region-matched controls. However, hernias occurred in just 10% of cases, and the matched siblings had hernias diagnosed with the same frequency as the cases. An apparent excess of heart disorders among cases versus siblings seems likely to be an artifact of increased medical surveillance of cases.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1302564

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  13 in total

1.  Random-digit dialing for control selection in childhood cancer studies: the geographic proximity and demographics within matched sets.

Authors:  P A Sakkinen; R K Severson; J A Ross; L L Robison
Journal:  Am J Public Health       Date:  1995-04       Impact factor: 9.308

Review 2.  Cancer risks among studies of medical diagnostic radiation exposure in early life without quantitative estimates of dose.

Authors:  Mark P Little; Richard Wakeford; Simon D Bouffler; Kossi Abalo; Michael Hauptmann; Nobuyuki Hamada; Gerald M Kendall
Journal:  Sci Total Environ       Date:  2022-03-26       Impact factor: 10.753

3.  Is There a Predisposition Gene for Ewing's Sarcoma?

Authors:  R L Randall; S L Lessnick; K B Jones; L G Gouw; J E Cummings; L Cannon-Albright; J D Schiffman
Journal:  J Oncol       Date:  2010-03-15       Impact factor: 4.375

Review 4.  Children's exposure to diagnostic medical radiation and cancer risk: epidemiologic and dosimetric considerations.

Authors:  Martha S Linet; Kwang Pyo Kim; Preetha Rajaraman
Journal:  Pediatr Radiol       Date:  2008-12-16

Review 5.  Are pre- or postnatal diagnostic X-rays a risk factor for childhood cancer? A systematic review.

Authors:  Renate Schulze-Rath; Gaël P Hammer; Maria Blettner
Journal:  Radiat Environ Biophys       Date:  2008-06-05       Impact factor: 1.925

6.  Risk of childhood cancer and adult lung cancer after childhood exposure to passive smoke: A meta-analysis.

Authors:  P Boffetta; J Trédaniel; A Greco
Journal:  Environ Health Perspect       Date:  2000-01       Impact factor: 9.031

7.  Epidemiology and therapies for metastatic sarcoma.

Authors:  Ernest K Amankwah; Anthony P Conley; Damon R Reed
Journal:  Clin Epidemiol       Date:  2013-05-16       Impact factor: 4.790

8.  The epidemiology of sarcoma.

Authors:  Zachary Burningham; Mia Hashibe; Logan Spector; Joshua D Schiffman
Journal:  Clin Sarcoma Res       Date:  2012-10-04

Review 9.  Childhood cancer: overview of incidence trends and environmental carcinogens.

Authors:  S H Zahm; S S Devesa
Journal:  Environ Health Perspect       Date:  1995-09       Impact factor: 9.031

Review 10.  Pesticides and childhood cancer.

Authors:  S H Zahm; M H Ward
Journal:  Environ Health Perspect       Date:  1998-06       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.